1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present...
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received...
Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know
ResMed has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
1 Large-Cap Stock to Target This Week and 2 We Brush Off
1 S&P 500 Stock to Research Further and 2 We Turn Down